<DOC>
	<DOCNO>NCT00557908</DOCNO>
	<brief_summary>The von Willebrand Disease Prophylaxis Network ( VWD PN ) international study group form goal investigate role prophylaxis clinically severe VWD non-responsive treatment ( ) .</brief_summary>
	<brief_title>The Von Willebrand Disease ( VWD ) International Prophylaxis Study</brief_title>
	<detailed_description>The common indication vWD prophylaxis include joint bleeding , epistaxis , gastrointestinal ( GI ) bleeding , menorrhagia . Thus , effort establish optimal treatment regimen indication , period prospective evaluation , primary focus research . Other goal include retrospective study effect prophylaxis bleeding frequency , retrospective natural history study GI bleeding VWD .</detailed_description>
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<criteria>Type 1 : eligible participation ≤20 % RCo and/or ≤20 % FVIII ; DDAVP nonresponsive , define occurrence bleed episode respond satisfactorily desmopressin , deem nonresponsive priori investigator ; Bleeding indication criterion meet Type 2 : eligible participation DDAVP nonresponsive , define occurrence bleed episode respond satisfactorily desmopressin , deem nonresponsive priori investigator ; Type 2B ; Bleeding indication criterion meet Type 3 : eligible participation Bleeding indication criterion meet Bleeding Indication Criteria : Joint Bleeding : documentation least two apparently spontaneous bleed episode joint six month prior enrollment ; three apparently spontaneous bleed episodes different joint six month prior enrollment . GI Bleeding : history two severe GI bleeding episode associate either drop hemoglobin ≥ 2 g/dl require red blood cell transfusion treatment VWD concentrate . Failure identify cause bleed . Menorrhagia : diagnosis menorrhagia ; prospectively complete Pictorial Blood Assessment Chart score &gt; 185 require treatment VWD product menstrual bleed one occasion year prior enrollment . Normal cervical cytology ( PAP ) within six month prior enrollment female ≥ 18 year age . Epistaxis 1 . Three bleed episode sixmonth period require treatment VWD concentrate red cell transfusion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Von Willebrand Disease</keyword>
	<keyword>VWD</keyword>
	<keyword>prophylaxis</keyword>
</DOC>